TCT-523 In-Hospital, 30-Day, and 6-Month Outcomes of Valve-in-Valve Transcatheter Mitral Valve Replacement vs Redo Surgical Mitral Valve Replacement

Authors

Waqas Ullah, Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania
Anas Hashem, Rochester Regional HealthFollow
Muhammad Khan, West Virginia University, Morgantown, West Virginia
Smitha Gowda, Methodist Hospital, Houston, Texas
Fnu Salman, Mercy Saint Vincent Medical Center, Toledo, Ohio
Samarthkumar Thakkar, Houston Methodist, Houston, TexasFollow

Department

Medicine

Document Type

Conference Proceeding

Publication Title

Journal of the American College of Cardiology

Conference Name

TCT 2022

Conference Date

2022-09

First Page

B214

DOI

10.1016/j.jacc.2022.08.616

Volume

80

Issue

12, Supplement

Publication Date

9-2022

Recommended Citation

Ullah, W., Hashem, A., Khan, M., Gowda, S., Salman, F., & Thakkar, S. (2022). TCT-523 In-Hospital, 30-Day, and 6-Month Outcomes of Valve-in-Valve Transcatheter Mitral Valve Replacement vs Redo Surgical Mitral Valve Replacement. Journal of the American College of Cardiology, 80 (12, Supplement), B214. https://doi.org/10.1016/j.jacc.2022.08.616